[go: up one dir, main page]

FR3029411B1 - USE OF ESTERS WITH 1,3-BUTANEDIOL OF AMINO ACID N-ACYLATED DERIVATIVES AS A HUMAN SKIN LIGHTENING AGENT - Google Patents

USE OF ESTERS WITH 1,3-BUTANEDIOL OF AMINO ACID N-ACYLATED DERIVATIVES AS A HUMAN SKIN LIGHTENING AGENT Download PDF

Info

Publication number
FR3029411B1
FR3029411B1 FR1461913A FR1461913A FR3029411B1 FR 3029411 B1 FR3029411 B1 FR 3029411B1 FR 1461913 A FR1461913 A FR 1461913A FR 1461913 A FR1461913 A FR 1461913A FR 3029411 B1 FR3029411 B1 FR 3029411B1
Authority
FR
France
Prior art keywords
butanediol
esters
amino acid
human skin
skin lightening
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1461913A
Other languages
French (fr)
Other versions
FR3029411A1 (en
Inventor
Laetitia Cattuzzato
Sandy Dumont
Jerome Guilbot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe dExploitation de Produits pour les Industries Chimiques SEPPIC SA
Original Assignee
Societe dExploitation de Produits pour les Industries Chimiques SEPPIC SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe dExploitation de Produits pour les Industries Chimiques SEPPIC SA filed Critical Societe dExploitation de Produits pour les Industries Chimiques SEPPIC SA
Priority to FR1461913A priority Critical patent/FR3029411B1/en
Publication of FR3029411A1 publication Critical patent/FR3029411A1/en
Application granted granted Critical
Publication of FR3029411B1 publication Critical patent/FR3029411B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Birds (AREA)
  • Cosmetics (AREA)
FR1461913A 2014-12-04 2014-12-04 USE OF ESTERS WITH 1,3-BUTANEDIOL OF AMINO ACID N-ACYLATED DERIVATIVES AS A HUMAN SKIN LIGHTENING AGENT Active FR3029411B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1461913A FR3029411B1 (en) 2014-12-04 2014-12-04 USE OF ESTERS WITH 1,3-BUTANEDIOL OF AMINO ACID N-ACYLATED DERIVATIVES AS A HUMAN SKIN LIGHTENING AGENT

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1461913 2014-12-04
FR1461913A FR3029411B1 (en) 2014-12-04 2014-12-04 USE OF ESTERS WITH 1,3-BUTANEDIOL OF AMINO ACID N-ACYLATED DERIVATIVES AS A HUMAN SKIN LIGHTENING AGENT

Publications (2)

Publication Number Publication Date
FR3029411A1 FR3029411A1 (en) 2016-06-10
FR3029411B1 true FR3029411B1 (en) 2018-03-02

Family

ID=52469135

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1461913A Active FR3029411B1 (en) 2014-12-04 2014-12-04 USE OF ESTERS WITH 1,3-BUTANEDIOL OF AMINO ACID N-ACYLATED DERIVATIVES AS A HUMAN SKIN LIGHTENING AGENT

Country Status (1)

Country Link
FR (1) FR3029411B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3066195B1 (en) * 2017-05-12 2019-06-07 Societe D'exploitation De Produits Pour Les Industries Chimiques Seppic PROCESS FOR SYNTHESIZING AN N-ACYL COMPOUND WITHOUT USING ORGANIC SOLVENT OR ACID CHLORIDE

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68916197T2 (en) * 1988-03-30 1994-09-29 Univ Boston COMPOSITION FOR IN-VIVO OR IN-VITRO INCREASE IN MELANINE CONTENT OF THE MELANOCYTES AND THEIR USE IN-VITRO.
FR2936152B1 (en) * 2008-09-24 2010-11-12 Seppic Sa MONOGLYCERIDE OF N-UNDECYLENOYL PHENYLALANINE, PROCESS FOR THE PREPARATION AND USE OF GLYCERIC ESTERS OF N-UNDECYLENOYL PHENYLALANINE AS A SKINLIGHTENING AGENT
FR2981932B1 (en) * 2011-10-27 2014-10-31 Seppic Sa NOVEL ESTERS OF N-ACYL DERIVATIVES OF AMINO ACIDS AND DIOLS, PROCESS FOR THEIR PREPARATION, AND USE IN COSMETICS AND AS A MEDICINAL PRODUCT

Also Published As

Publication number Publication date
FR3029411A1 (en) 2016-06-10

Similar Documents

Publication Publication Date Title
ECSP17078433A (en) OBETICOLIC ACID COMPOSITIONS AND METHODS OF USE
EP3174874A4 (en) BERBERIN SALTS, URSODESOXYCHOLIC SALTS AND COMBINATIONS, METHODS OF PREPARATION AND APPLICATION THEREOF
DK3334422T3 (en) USE OF CANNABIDIOLIC ACID IN THE TREATMENT OF EPILEPSY
MA41031A (en) CYSTEAMINE-FATTY ACID CONJUGATES AND THEIR USE AS AUTOPHAGIC ACTIVATORS
HUE053946T2 (en) 4'-Fluoronucleosides, 4'-fluoronucleotides and their analogues for the treatment of HCV
EP3271352A4 (en) PIPERAZINE CARBAMATES AND METHODS OF PREPARATION AND USE THEREOF
PL3145522T3 (en) The combination, composition, and method of administering the combination or composition to animals
MA53108A (en) USE OF PRG4 AS ANTI-INFLAMMATORY AGENT
DK3169232T3 (en) INTERMITTING MEASUREMENT OF THE PARTIAL PRESSURE OF AN ANALYT IN SKIN TISSUE
EP2967836A4 (en) CRYOPRESERVATION OF VIABLE HUMAN SKIN SUBSTITUTES
PT4129270T (en) MODIFIED-RELEASE ORAL AMINO ACID FORMULATIONS
MX2017006953A (en) Medicaments for slowing parkinson's disease.
EP3352771A4 (en) OMBILICAL TISSUE COMPOSITIONS AND METHODS OF USE
MA40759A (en) PYRROLOPYRIDINE-SUBSTITUTED BY METHYL AND TRIFLUOROMETHYL RORC2 MODULATORS AND THEIR METHODS OF USE
EP3399957A4 (en) SKIN REFRESHING COMPOSITIONS
MA43730A (en) MALASSEZINE AND RELATED ANALOGUES AS SKIN LIGHTENING AGENTS
LT3151853T (en) GLUTAMIC ACID DECARBOXYLASE (GAD) FOR USE IN THE TREATMENT OF AUTOIMMUNE DISEASE
EP2950779A4 (en) METHODS OF LAUNDERING THE SKIN BY USING CANOLA EXTRACTS
FR3027518B1 (en) USE OF ISOSORBIDE ESTER AND N-ACYL DERIVATIVES OF AMINO ACIDS AS AN ANTI-AGING AGENT FOR HUMAN SKIN
MA41377A (en) LEVODOPA AND CARBIDONA INTESTINAL GEL AND PROCEDURES FOR USE
FR3023477B1 (en) COSMETIC USE OF SPICULISPORIC ACID AS DEODORANT ACTIVE
EP2934184A4 (en) XANTHOPHYLL COMPOSITIONS AND METHODS OF USE
EP2830608A4 (en) PHENYLUREA AND PHENYLCARBAMATE DERIVATIVES AS INHIBITORS OF PROTEIN AGGREGATION
EP3395324A4 (en) ANTI-AGING AGENT AND ANTI-AGING COMPOSITION FOR THE SKIN
EP3597040A4 (en) AGENTS FOR FIGHTING PLANT DISEASES

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20160610

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12